Work

Abstract LB-224: A randomized phase 2 study of two doses of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC)

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-lb-224

Authors: Emmanuel S. Antonarakis, Elisabeth I. Heath, David C. Smith, Dana Rathkopf, Amanda L. Blackford, Daniel C. Danila, Serina King, Anja Frost, A. Seun Ajiboye, Ming Zhao, Janet Mendonca, Sushant K. Kachhap, Michelle A. Rudek, Michael A. Carducci

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The Barbara Ann Karmanos Cancer Institute, University of Michigan, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2014368757

Cites:

Cited by:

Related to: 10